Pfizer (PFE) FCF Payout Ratio (2009 - 2026)

Pfizer (PFE) has reported FCF Payout Ratio for 18 consecutive years, with 1.12 the latest figure, recorded in Q1 2026.

• In Q1 2026, FCF Payout Ratio fell 18.46% year-over-year to 1.12; the TTM figure through Mar 2026 stood at 1.03 (down 75.63% YoY), while the FY2025 annual figure was 1.08, up 11.33% from the prior year.
• FCF Payout Ratio advanced to 1.12 in Q1 2026 per PFE's latest filing, from 0.54 in the prior quarter.
• Across five years, FCF Payout Ratio topped out at 31.55 in Q2 2023 and bottomed at 2.04 in Q2 2025.
• Historically, FCF Payout Ratio has averaged 3.1 across 5 years, with a median of 0.55 in 2023.
• On a YoY basis, FCF Payout Ratio climbed as much as 8173.45% in 2023 and fell as far as 460.69% in 2023.
• Pfizer's FCF Payout Ratio stood at 0.3 in 2022, then soared by 82.41% to 0.55 in 2023, then surged by 220.69% to 1.77 in 2024, then plunged by 69.31% to 0.54 in 2025, then soared by 106.65% to 1.12 in 2026.
• Business Quant data shows PFE's FCF Payout Ratio at 1.12 in Q1 2026, 0.54 in Q4 2025, and 0.61 in Q3 2025.